Solomon Graf
Hematology & Oncology · Seattle, WANPI 1457508632
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,625 of the $1,710 with a category attached, or 95.0%. Pfizer accounts for 95.0% of it on its own, with 1 other manufacturer making up the rest.
Across 3 payments — averaging $570.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$2K
- AbbVie$85
Across 201 payments — averaging $5364.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Beigene, Ltd.$519K
- TG Therapeutics, Inc.$159K
- Acerta Pharma LLC$97K
- GSK$82K
- Janssen Research & Development, LLC$78K
- Genentech, Inc.$46K
- plus $97K from 5 others
What the payments were for
- Consulting fees$1,62595%
- Food & beverage$855%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADCETRIS$1,625
How this compares
$1,710 in reported general payments places this provider in the 55th percentile of 349 hematology & oncology providers in Washington.
Other hematology & oncology in Seattle
- John PesandoSeattle$15.7M
- Jill JohnsenSeattle$991K
- Fengting YanSeattle$841K
- John PagelSeattle$725K
- Lawrence FongSeattle$546K
- Langdon MillerSeattle$457K
- Mazyar ShadmanSeattle$226K
- Catherine LeeSeattle$199K
- Celestia HiganoSeattle$164K
- Ryan CassadaySeattle$151K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.